Literature DB >> 7788641

Concomitant protein phosphorylation and endogenous acetylcholine release induced by nicotine: dependency on neuronal nicotinic receptors and desensitization.

E L Ochoa1, S M O'Shea.   

Abstract

1. Nicotine stimulated two Ca(2+)-dependent processes in rat frontal cortex synaptosomes: the phosphorylation of an 80-kDa protein band and the release of endogenous ACh.3 Both effects were mediated by neuronal nAChRs and coincided with depolarization of the synaptosomal plasma membrane induced by the drug. Changes in the state of phosphorylation of the 80-kDa band (presumed to contain synapsin I) were correlated with changes in the release of ACh as follows, from 2 to 4. 2. Blockade of predominant, nerve terminal P-type Ca2+ channels with omega-agatoxin-IVA, did not prevent nicotine from stimulating ACh release. In contrast, exposure to the toxin partially inhibited the release promoted by the depolarizing agent veratridine and attenuated protein phosphorylation induced by either nicotine or veratridine. Taken together, these data suggest that, upon nicotine stimulation. Ca2+ enters nerve terminals through two distinct pathways. The first, via Ca2+ channels, is necessary (but not sufficient) for both nicotine-induced phosphorylation and ACh release. The second, both necessary and sufficient for nicotine-induced phosphorylation and release, is the neuronal nAChR itself. 3. Preincubation of the synaptosomes with a subeffective concentration of nicotine inactivated both nicotine-induced ACh liberation and phosphorylation. This shows that diminished release is associated to decreased phosphorylation of the 80-kDa protein band, most likely as a consequence of nicotine-promoted nAChR desensitization. 4. Augmented ACh release and phosphorylation of the 80-kDa protein band were achieved by using the protein phosphatase inhibitor okadaic acid. However, okadaic acid did not summate with either nicotine or veratridine to increase ACh release further. This is probably because okadaic acid, as in other neurons, increases intracellular Ca2+ (Cholewinski et al., 1993), thus promoting desensitization of ACh release.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7788641     DOI: 10.1007/bf02088714

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  45 in total

1.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

2.  Studies of the effect of nicotine on synaptosomal calcium accumulation using FURA-2.

Authors:  C J Hillard; W K Graf
Journal:  NIDA Res Monogr       Date:  1990

3.  Neuronal acetylcholine receptors that bind alpha-bungarotoxin with high affinity function as ligand-gated ion channels.

Authors:  Z W Zhang; S Vijayaraghavan; D K Berg
Journal:  Neuron       Date:  1994-01       Impact factor: 17.173

4.  Synapsin II phosphorylation and catecholamine release in bovine adrenal chromaffin cells: additive effects of histamine and nicotine.

Authors:  J A Firestone; M D Browning
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

5.  Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation.

Authors:  C Rapier; G G Lunt; S Wonnacott
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

6.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.

Authors:  M J Marks; J R Pauly; S D Gross; E S Deneris; I Hermans-Borgmeyer; S F Heinemann; A C Collins
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

7.  Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific.

Authors:  E M Sanderson; A L Drasdo; K McCrea; S Wonnacott
Journal:  Brain Res       Date:  1993-07-23       Impact factor: 3.252

8.  In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.

Authors:  R D Schwartz; K J Kellar
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

9.  Tetrodotoxin-resistant electric activity in presynaptic terminals.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

10.  Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin omega-Aga-IVA.

Authors:  D A Protti; O D Uchitel
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

View more
  6 in total

Review 1.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 2.  Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.

Authors:  E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

3.  Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes.

Authors:  C R Vibat; J A Lasalde; M G McNamee; E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1995-08       Impact factor: 5.046

4.  Layer-specific cholinergic control of human and mouse cortical synaptic plasticity.

Authors:  Matthijs B Verhoog; Joshua Obermayer; Christian A Kortleven; René Wilbers; Jordi Wester; Johannes C Baayen; Christiaan P J De Kock; Rhiannon M Meredith; Huibert D Mansvelder
Journal:  Nat Commun       Date:  2016-09-08       Impact factor: 14.919

Review 5.  Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Authors:  Enrique L M Ochoa; Jose Lasalde-Dominicci
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

6.  Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.

Authors:  Weston A Nichols; Brandon J Henderson; Christopher B Marotta; Caroline Y Yu; Chris Richards; Dennis A Dougherty; Henry A Lester; Bruce N Cohen
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.